— Why it moved
Why VVOS Stock Spiked and Faded Today — August 31, 2026
Vivos Therapeutics pushed out a joint venture agreement and a debt conversion deadline, but a brief premarket pop turned into a brutal collapse.
What moved VVOS stock
Vivos Therapeutics manufactures medical devices for obstructive sleep apnea. They announced a Florida sleep center partnership promising potential revenue in 2027, coinciding with an equity raise deadline for a debt conversion agreement. Momentum traders recycled the press release early, but there was no sustained buying behind it.
The mechanics
A float of 17.4 million shares and a micro-cap valuation allowed extreme volume to churn over 530 million shares. The stock gapped up 57.8% before the session's start as traders fought over low-priced shares before the dumping began.
VVOS by the numbers
The alert window
The alert hit at 9:07 AM at $0.433. After a quick 4% drop to $0.4157, the price topped out at $0.4777 just three minutes later. That offered a quick 10.3% gain, but the stock spent only 13 minutes above the alert price all day.
How VVOS's move ended
The ticker completely dissolved, closing at $0.1954 for a 54.9% loss from the alert and a fresh 52-week low. Heavy dilution concerns and financing pressure took complete control once retail buyers stepped aside.
The tell: Premarket pops tied to distant revenue projections usually hide active financing deadlines.